KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aquestive Therapeutics (AQST) Tax Provisions: 2023-2024

Historic Tax Provisions for Aquestive Therapeutics (AQST) over the last 2 years, with Dec 2024 value amounting to -$14,000.

  • Aquestive Therapeutics' Tax Provisions fell 113.86% to -$14,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $231,000, marking a year-over-year change of. This contributed to the annual value of -$14,000 for FY2024, which is 105.71% down from last year.
  • As of FY2024, Aquestive Therapeutics' Tax Provisions stood at -$14,000, which was down 105.71% from $245,000 recorded in FY2023.
  • Over the past 5 years, Aquestive Therapeutics' Tax Provisions peaked at $245,000 during FY2023, and registered a low of -$14,000 during FY2024.
  • Its 2-year average for Tax Provisions is $115,500, with a median of $115,500 in 2023.
  • Data for Aquestive Therapeutics' Tax Provisions shows a maximum YoY tumbled of 105.71% (in 2024) over the last 5 years.
  • Aquestive Therapeutics' Tax Provisions (Yearly) stood at $245,000 in 2023, then tumbled by 105.71% to -$14,000 in 2024.